Stock PIHLIS PIHLAJALINNA OYJ
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pihlajalinna Oyj

Equities

PIHLIS

FI4000092556

Healthcare Facilities & Services

Market Closed - Nasdaq Helsinki
Other stock markets
 11:29:49 2024-05-31 am EDT 		5-day change 1st Jan Change
9.3 EUR +1.53% Intraday chart for Pihlajalinna Oyj +1.09% +31.73%
May. 27 Pihlajalinna Plc Appoints Anu Kallio as Director, Private Healthcare Services and as Member of the Management Team, Effective 1 December 2024 CI
May. 21 Pihlajalinna Plc Announces Executive Changes CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 345.6 212.2 285.6 192.1 159.3 209.2 - -
Enterprise Value (EV) 1 538.3 407 480.3 577.8 512 549.3 555.2 548.9
P/E ratio 102 x 24.1 x 14.2 x 20.3 x 37.2 x 11 x 9.34 x 8.85 x
Yield - 2.13% 2.37% - 0.99% 3.44% 3.36% 4.12%
Capitalization / Revenue 0.67 x 0.42 x 0.49 x 0.28 x 0.22 x 0.3 x 0.29 x 0.32 x
EV / Revenue 1.04 x 0.8 x 0.83 x 0.84 x 0.71 x 0.78 x 0.76 x 0.83 x
EV / EBITDA 9.77 x 7.45 x 7.36 x 9 x 6.35 x 6.11 x 5.93 x 5.87 x
EV / FCF 25.2 x 10.9 x 11.4 x 16.1 x 9.13 x 12.4 x 11.3 x 12.8 x
FCF Yield 3.98% 9.17% 8.77% 6.21% 11% 8.07% 8.89% 7.83%
Price to Book 3.42 x 1.93 x 2.4 x 1.55 x 1.08 x 1.27 x 1.23 x 1.18 x
Nbr of stocks (in thousands) 22,620 22,618 22,594 22,550 22,562 22,495 - -
Reference price 2 15.28 9.380 12.64 8.520 7.060 9.300 9.300 9.300
Announcement Date 2/14/20 2/19/21 2/18/22 2/17/23 2/14/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 518.6 508.7 577.8 690.5 720 703.8 728.9 660.6
EBITDA 1 55.1 54.6 65.3 64.2 80.6 89.97 93.68 93.47
EBIT 1 20.8 20.8 30.3 18.6 29.1 40.7 43.07 41.6
Operating Margin 4.01% 4.09% 5.24% 2.69% 4.04% 5.78% 5.91% 6.3%
Earnings before Tax (EBT) 1 6.3 13.8 24.2 1.5 8.2 28.44 31.07 30.73
Net income 1 3.4 8.7 20.1 9.5 5.7 18.51 22.91 23.65
Net margin 0.66% 1.71% 3.48% 1.38% 0.79% 2.63% 3.14% 3.58%
EPS 2 0.1500 0.3900 0.8900 0.4200 0.1900 0.8426 0.9955 1.050
Free Cash Flow 1 21.4 37.3 42.1 35.9 56.1 44.33 49.33 42.97
FCF margin 4.13% 7.33% 7.29% 5.2% 7.79% 6.3% 6.77% 6.5%
FCF Conversion (EBITDA) 38.84% 68.32% 64.47% 55.92% 69.6% 49.28% 52.66% 45.97%
FCF Conversion (Net income) 629.41% 428.74% 209.45% 377.89% 984.21% 239.54% 215.38% 181.66%
Dividend per Share 2 - 0.2000 0.3000 - 0.0700 0.3200 0.3125 0.3833
Announcement Date 2/14/20 2/19/21 2/18/22 2/17/23 2/14/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 154.7 163.1 173.7 165.2 188.4 187.8 183.6 165.6 183 183.2 177.8 161.6 182.4
EBITDA 1 14.9 16.5 16.9 18.9 12 21.4 18 20.5 20.7 26 21 21.35 22.3
EBIT 1 6 5.9 5.2 7.3 0.1 8.9 5.1 7.4 7.7 13 8.467 8.867 9.733
Operating Margin 3.88% 3.62% 2.99% 4.42% 0.05% 4.74% 2.78% 4.47% 4.21% 7.1% 4.76% 5.49% 5.34%
Earnings before Tax (EBT) 1 4.6 -2.7 2.5 4.5 -2.8 7.5 2.4 4.4 -6.1 10.2 5.5 5.95 6.8
Net income 1 4.3 5.3 1.7 3.3 -0.7 5.5 2 3.5 -5.2 7.2 3.6 3.9 4.8
Net margin 2.78% 3.25% 0.98% 2% -0.37% 2.93% 1.09% 2.11% -2.84% 3.93% 2.02% 2.41% 2.63%
EPS 2 0.1900 0.2300 0.0800 0.1400 -0.0300 0.2400 0.0700 0.1300 -0.2500 0.3000 0.1600 0.1750 0.2100
Dividend per Share - - - - - - - - - - - - -
Announcement Date 2/18/22 5/5/22 8/12/22 11/4/22 2/17/23 4/28/23 8/11/23 11/3/23 2/14/24 5/3/24 - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 193 195 195 386 353 340 346 340
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 3.497 x 3.568 x 2.982 x 6.008 x 4.376 x 3.78 x 3.693 x 3.634 x
Free Cash Flow 1 21.4 37.3 42.1 35.9 56.1 44.3 49.3 43
ROE (net income / shareholders' equity) 3.03% 8.1% 16.1% 6.2% 3.4% 12.4% 14% 13.5%
ROA (Net income/ Total Assets) - - 4.48% 1.7% 0.86% 3.26% 4% 4.23%
Assets 1 - - 449.2 559.3 659.5 568.6 572.9 558.6
Book Value Per Share 2 4.470 4.850 5.270 5.500 6.560 7.340 7.550 7.860
Cash Flow per Share 2 1.630 2.030 2.520 2.880 3.500 3.710 3.600 3.000
Capex 1 15.4 9.9 14.8 29 22.9 30.2 36.7 30.7
Capex / Sales 2.97% 1.95% 2.56% 4.2% 3.18% 4.3% 5.03% 4.64%
Announcement Date 2/14/20 2/19/21 2/18/22 2/17/23 2/14/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Pihlajalinna Oyj

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
9.3 EUR
Average target price
9.225 EUR
Spread / Average Target
-0.81%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
PIHLAJALINNA OYJ Stock Pihlajalinna Oyj
+31.73% 227M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+25.52% 88.99B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-24.52% 74.82B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
-3.80% 25.03B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+4.31% 17.88B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-14.25% 16.43B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+2.97% 15.77B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+79.20% 13.21B
NATERA, INC. Stock Natera, Inc.
+70.11% 13.08B
DAVITA INC. Stock DaVita Inc.
+40.44% 12.9B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. PIHLIS Stock
  4. Financials Pihlajalinna Oyj